NCT06971445View on ClinicalTrials.gov

Effect of Omega-3 Supplementation on Pregnant Outcomes and Inflammation Markers of Women Infected With HIV Using Antiretroviral Therapy

NAEnrolling by invitationINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

May 14, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

December 31, 2029

Conditions
Pregnant HIV Positive Women
Interventions
DIETARY_SUPPLEMENT

omega-3 polyunsaturated fatty acids (PUFA n-3)

1280 mg of omega-3 polyunsaturated fatty acids (650mg EPA, 450mg DHA, and 179mg ALA) per day for 8 weeks

DIETARY_SUPPLEMENT

Olive oil (placebo)

Softgels containing extra virgin olive oil, with a similar appearance to the experimental group, were given to participants for 8 weeks.

Trial Locations (1)

11000

Instituto Nacional de Perinatologia, Mexico City

All Listed Sponsors
lead

Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes

OTHER_GOV